zidovudine has been researched along with galactose in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frohlick, C; Hall, ET; Ilsley, DD; Kuchta, RD; Melançon, P; Steet, R; Yan, JP | 1 |
| Pace, JG; Scovill, JP; Thompson, WL | 1 |
| Garg, M; Jain, NK | 1 |
3 other study(ies) available for zidovudine and galactose
| Article | Year |
|---|---|
3'-Azidothymidine (zidovudine) inhibits glycosylation and dramatically alters glycosphingolipid synthesis in whole cells at clinically relevant concentrations.
Topics: Carbohydrate Conformation; Carbohydrate Sequence; Cell Line; DNA Replication; Dose-Response Relationship, Drug; Galactose; Glycosphingolipids; Glycosylation; Golgi Apparatus; Hexosamines; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Molecular Sequence Data; Radioisotope Dilution Technique; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tritium; Tumor Cells, Cultured; Zidovudine | 1995 |
Drugs that show protective effects from ricin toxicity in in vitro protein synthesis assays.
Topics: Animals; Antimetabolites; Brefeldin A; Carbohydrate Sequence; Chlorocebus aethiops; Cyclopentanes; Drug Synergism; Galactose; Imidazoles; In Vitro Techniques; Lactose; Molecular Sequence Data; Protein Synthesis Inhibitors; Reticulocytes; Ricin; Structure-Activity Relationship; Vero Cells; Zidovudine | 1995 |
Reduced hematopoietic toxicity, enhanced cellular uptake and altered pharmacokinetics of azidothymidine loaded galactosylated liposomes.
Topics: Animals; Anti-HIV Agents; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Female; Galactose; Half-Life; Hematologic Diseases; Hematopoiesis; Liposomes; Macrophages; Male; Rats; Rats, Sprague-Dawley; Ricinus; Solubility; Tissue Distribution; Zidovudine | 2006 |